Ross\Johnson & Associates’s Humana HUM Stock Holding History

Ross\Johnson & Associates’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$256	–	277
2025 Q4	$256	Buy	+1	New	+$262	﹤0.01%	222

Other funds holding HUM

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Ross\Johnson & Associates's HUM Position: Q1 2026 in Review

Ross\Johnson & Associates sold out of Humana (HUM) in Q1 2026, closing a stake of 1 share — an estimated $256 sold.

Ross\Johnson & Associates first reported a position in HUM in Q4 2025 and held it in 1 quarter. The position peaked at $256 in Q4 2025. 780 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

Ross\Johnson & Associates reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
Ross\Johnson & Associates sold 1 Humana share in Q1 2026, an estimated $256.
Ross\Johnson & Associates first reported a position in Humana in Q4 2025 and held it in 1 quarter.
Ross\Johnson & Associates's Humana position peaked at $256 in Q4 2025.
780 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.